DR. KRISTINA VALERIE THOMAS, M.D.
Medical Practice at Mountain View Dr, Pittsburgh, PA

License number

Pennsylvania 35-094182

Personal information

See more information about KRISTINA VALERIE THOMAS at radaris.com

Name

Address

Phone

Kristina Thomas

5610 Bushnell Campbell Rd, Kinsman, OH 44428

Kristina Thomas

5303 Main St, Centerburg, OH 43011

(740) 404-4195

Kristina Thomas

411 Saint Vincent St, Philadelphia, PA 19111

Kristina Thomas, age 53

438 Coronado Dr, Fairborn, OH 45324

Kristina Thomas

4416 Hubble Rd, Cincinnati, OH 45247

(513) 385-2793

Professional information

Dr. Kristina V Thomas, Westlake OH - MD (Doctor of Medicine)

Specialties:

Ophthalmology

Age:

Address:

University Hosp Eye Institute
950 Clague Rd SUITE B, Westlake 44145
(440) 250-2020 (Phone)

Certifications:

Ophthalmology, 2011

Awards:

Healthgrades Honor Roll

Languages:

English

Hospitals:

University Hosp Eye Institute
950 Clague Rd SUITE B, Westlake 44145
University Hospitals Case Medical Center
11100 Euclid Ave, Cleveland 44106

Education:

Medical School
Drexel University College of Medicine
Graduated: 2004

Kristina Valerie Thomas, Cleveland OH

Specialties:

Ophthalmology

Work:

UH Case Medical Center
11100 Euclid Ave, Cleveland, OH 44106 Uh Hudson Health Center
5778 Darrow Rd, Hudson, OH 44236 Uh Westlake Health Center Bldg B
950 Clague Rd, Westlake, OH 44145 Uh Landerbrook Health Center
5850 Landerbrook Dr, Cleveland, OH 44124

Education:

Drexel University(2004)

Hospital &Amp; Health Care Professional

Location:

Cleveland/Akron, Ohio Area

Industry:

Hospital & Health Care

Surfactant-Based Antimicrobial Solution For Inhalation

US Patent:

2009005, Feb 26, 2009

Filed:

Aug 21, 2008

Appl. No.:

12/195544

Inventors:

Tim Corcoran - Pittsburgh PA, US
Amy Lise Marcinkowski - Syracuse NY, US
Joseph Pilewski - Pittsburgh PA, US
Kristina Thomas - Pittsburgh PA, US

International Classification:

A61K 9/12, A61K 31/7036, A61K 31/546, A61K 31/427, A61K 38/12, A61K 31/7052, A61K 31/155, A61K 31/65, A61P 31/10, A61P 31/04, A61P 31/12, A61K 31/5377, A61K 31/407, A61K 31/44, A61K 31/496, A61K 31/351, A61K 31/7048

US Classification:

424 45, 514 40, 514203, 51421015, 514 10, 514 29, 514636, 514152, 5142368, 51421013, 514354, 51425411, 514459, 514 31

Abstract:

A surfactant can be added, safely and effectively, to a drug solution containing any antimicrobial agent, such as an antibiotic like tobramycin, that is suitable for administration to the lungs via inhalation. Thus, when an aerosolized drug solution includes surfactant, Marangoni flows cause the drug particles, once deposited in the lungs, to spread over a wider surface area, thereby ensuring greater antimicrobial efficacy. A solution that contains, for example, an antibiotic and tyloxapol or another surfactant providing a similar surface tension to the composition is optimally delivered by the functional combination of a breath-actuated nebulizer and a high-flow compressor.

Method Of Treating T Cell Mediated Disorders

US Patent:

2011018, Jul 28, 2011

Filed:

Mar 6, 2009

Appl. No.:

12/921308

Inventors:

M. Edward Medof - Pepperpike OH, US
Michael G. Strainic - Westlake OH, US
Kristina V. Thomas - Lakewood OH, US
Jodi Arth - Cleveland OH, US
Juang Huang - Richmond Heights OH, US

International Classification:

A61K 39/395, A61K 38/00, A61K 48/00, A61P 31/22, A61P 27/02

US Classification:

4241581, 514 11, 514 44 R, 514 44 A

Abstract:

A method of treating a T-cell mediated disorders in a tissue includes administering to the tissue of the subject a therapeutically effective amount of a complement antagonist that substantially reduces T-cell differentiation or t-cell inflammatory cytokine generation.